Free shipping on orders over $300
Home Shop Weight Management

Category

Weight Management Peptides

Metabolic support & appetite regulation

Showing 3 products

Triple G research peptide vial
Save $10
5mg 10mg 20mg

Weight Management

Triple G

Triple G (LY3437943, CAS# 2381089-83-2) is a synthetic peptide compound classified as a triple receptor agonist with binding activity at the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GcgR). Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.

$90 $100
Buy Now
Tesamorelin research peptide vial
Save $15
10mg

Weight Management

Tesamorelin

Tesamorelin (TH9507, CAS# 218949-48-5) is a synthetic analogue of human growth hormone releasing hormone (hGHRH) comprising the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid group conjugated at the N-terminus. This N-terminal modification confers enhanced resistance to dipeptidyl peptidase IV (DPP-IV) enzymatic cleavage while preserving full GHRHR binding activity, making Tesamorelin a distinct pharmacological research tool compared to shorter GHRH fragments such as Sermorelin (29 AA) or Mod GRF 1-29. Supplied by BIOSTACKS as a lyophilized powder for in vitro laboratory research use. This compound has not been authorized by Health Canada for any therapeutic, clinical, or human use.

$180 $195
Buy Now
5-Amino-1MQ research peptide vial
Save $10
50mg

Weight Management

5-Amino-1MQ

5-Amino-1MQ (5-amino-1-methylquinolin-1-ium iodide, CAS 42464-96-0) is a synthetic quinolinium small molecule and selective substrate-site inhibitor of nicotinamide N-methyltransferase (NNMT), with a reported IC₅₀ of 1.2 μM. It is studied in vitro for its effects on the NAD⁺ salvage pathway, methionine cycle flux, and metabolic enzyme activity in cell culture models. Supplied by BIOSTACKS as powder for in vitro laboratory research use.

$120 $130
Buy Now